• Scaling R&D Drug Discovery: The Future Of Lab Automation

    Bio-IT World | In the coming decades, many of the grand challenges that society faces, from global food shortages to disease control and climate change, has the opportunity to be solved by biology. To achieve this, we must enable researchers within the biotech and healthcare ecosystems to be more productive than ever by improving scale, reproducibility, and accessibility.

    Sep 8, 2023

  • Illumina Names Jacob Thaysen of Agilent New CEO

    Bio-IT World | Illumina today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Illumina’s next Chief Executive Officer, effective September 25, 2023.

    Sep 5, 2023

  • Novel Biomarker Tracks Tightly With Tau Tangles In Alzheimer’s Disease

    Bio-IT World | Researchers in the U.S. and Sweden have identified a biomarker (MTBR-tau243) for Alzheimer’s disease that tracks with the amount of damaging tau tangles in the brain and, when combined with a specific phosphorylated tau species (p-tau205), is nearly as predictive of cognitive function as tau-positron emission tomography (tau-PET) imaging.

    Sep 5, 2023

  • Nanopore News from Oxford Nanopore, University of Missouri, New Genedata Product, More

    Bio-IT World | University of Missouri researchers developed an innovative method using nanopores; Oxford Nanopore speeds basecalling for MinKNOW; Standigm and Nashville Biosciences partner on early drug discovery research, and more.

    Aug 31, 2023

  • The First Commercial-Scale IDMO Smart Factory, Company Advancements, RNA Editing Platforms, More

    Bio-IT World | Cellares will use funding to launch the world’s first commercial-scale IDMO Smart Factory; Genesis Therapeutics plans to use Series B financing to elevate into a clinical stage company and further invest in its AI platform; Amber Bio will use funds to advance first-of-its-kind RNA editing platform; more.

    Aug 30, 2023